Items where Subject is "Cancer Research"

  • ASJC Scopus Subject Areas (3608)
  • Biochemistry, Genetics and Molecular Biology(all) (273)
  • Cancer Research (14)
    Number of items at this level: 14.
    B
  • Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. (2018) Saba N Baskoylu, Jill Yersak, Patrick O'Hern, Sarah Grosser, Jonah Simon, Sarah Kim, Kelsey Schuch, Maria Dimitriadi, Katherine S Yanagi, Jeremy Lins and Anne C Hart
  • Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. (2019) Oleg Blyuss, Alexey Zaikin, Valeriia Cherepanova, Daniel Munblit, Elena M Kiseleva, Olga M Prytomanova, Stephen W Duffy and Tatjana Crnogorac-Jurcevic
  • Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. (2022) Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui and Shoib Siddiqui
  • F
  • Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery. (2022) Sherif Ashraf Fahmy, Alyaa Dawoud, Yousra Ahmed Zeinelabdeen, Caroline Joseph Kiriacos, Kerolos Ashraf Daniel, Omar Eltahtawy, Miriam Mokhtar Abdelhalim, Maria Braoudaki and Rana A. Youness
  • Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders. (2019) Concetta Federico, Temitayo Owoka, Denise Ragusa, Valentina Sturiale, Domenica Caponnetto, Claudia Giovanna Leotta, Francesca Bruno, Helen Foster, Silvia Rigamonti, Giovanni Giudici, Giovanni Cazzaniga, Joanna Bridger, Cristina Sisu, Salvatore Saccone and Sabrina Tosi
  • G
  • Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention. (2020) Faiza Gaba, Oleg Blyuss, Xinting Liu, Shivam Goyal, Nishant Lahoti, Dhivya Chandrasekaran, Margarida Kurzer, Jatinderpal Kalsi, Saskia Sanderson, Anne Lanceley, Munaza Ahmed, Lucy Side, Aleksandra Gentry-Maharaj, Yvonne Wallis, Andrew Wallace, Jo Waller, Craig Luccarini, Xin Yang, Joe Dennis, Alison Dunning, Andrew Lee, Antonis C Antoniou, Rosa Legood, Usha Menon, Ian Jacobs and Ranjit Manchanda
  • Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women. (2020) Aleksandra Gentry-Maharaj, Oleg Blyuss, Andy Ryan, Matthew Burnell, Chloe Karpinskyj, Richard Gunu, Jatinderpal K. Kalsi, Anne Dawnay, Ines P. Marino, Ranjit Manchanda, Karen Lu, Wei Lei Yang, John F. Timms, Max Parmar, Steven J. Skates, Robert C. Bast, Ian J. Jacobs, Alexey Zaikin and Usha Menon
  • H
  • Molecular and biological characterization of a novel partitivirus from Talaromyces pinophilus. (2024) Sidra Hassan, Urayama Syun-ichi, Saba Shabeer, Tahseen Ali Kiran, Chien-Fu Wu, Hiromitsu Moriyama, Robert H.A. Coutts, Ioly Kotta Loizou and Atif Jamal
  • K
  • Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells. (2019) Uchini S Kosgodage, Pinar Uysal-Onganer, Amy MacLatchy, Rhys Mould, Alistair Nunn, Geoffrey Guy, Igor Kraev, Nicholas Chatterton, Jameel Inal, E. Louise Thomas, Jimmy Bell and Sigrun Lange
  • O
  • In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma. (2024) Sophie Orton, Rebecca Karkia, Denis Mustafov, Seley Gharanei, Maria Braoudaki, Alice Filipe, Suzana Panfilov, Sayeh Saravi, Nabeel Khan, Ioannis Kyrou, Emmanouil Karteris, Jayanta Chatterjee and Harpal S. Randeva
  • S
  • The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo. (2023) Zohreh Salari, Ahmad Khosravi, Elham Pourkhandani, Elaheh Molaakbari, Ehsan Salarkia, Alireza Keyhani, Iraj Sharifi, Hadi Tavakkoli, Samira Sohbati, Shahriar Dabiri, Guogang Ren and Mohammad Shafie’ei
  • The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. (2022) Sam Salek, Tatiana Ionova, Esther Natalie Oliva, Marike Andreas, Nicole Skoetz, Nina Kreuzberger and Edward Laane
  • Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling. (2008) Greg Shaw and David M. Prowse
  • W
  • Improved early detection of ovarian cancer using longitudinal multimarker models. (2020) Harry J. Whitwell, Jenny Worthington, Oleg Blyuss, Aleksandra Gentry-Maharaj, Andy Ryan, Richard Gunu, Jatinderpal Kalsi, Usha Menon, Ian Jacobs, Alexey Zaikin and John F. Timms